Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

1.52 (USD) • At close January 3, 2025
Bedrijfsnaam Rani Therapeutics Holdings, Inc.
Symbool RANI
Munteenheid USD
Prijs 1.525
Beurswaarde 87,577,003
Dividendpercentage 0%
52-weken bereik 1.3 - 8.75
Industrie Biotechnology
Sector Healthcare
CEO Mr. Talat Imran
Website https://www.ranitherapeutics.com

An error occurred while fetching data.

Over Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I

Vergelijkbare Aandelen

Inogen, Inc. logo

Inogen, Inc.

INGN

9.62 USD

Pharvaris N.V. logo

Pharvaris N.V.

PHVS

18.53 USD

Gossamer Bio, Inc. logo

Gossamer Bio, Inc.

GOSS

1.02 USD

Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc.

RLMD

0.47 USD

Kiniksa Pharmaceuticals, Ltd. logo

Kiniksa Pharmaceuticals, Ltd.

KNSA

20.31 USD

PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc.

PMVP

1.55 USD

Eagle Pharmaceuticals, Inc. logo

Eagle Pharmaceuticals, Inc.

EGRX

0.5 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)